Dr. Linda Brady, Ph.D., serves as the Director of the Division of Neuroscience and Basic Behavioral Science at the National Institute of Mental Health (NIMH). In this role, she provides scientific, programmatic, and administrative leadership for an extramural research program portfolio in basic neuroscience to support NIMH’s mission of transforming the understanding and treatment of mental illnesses. Dr. Brady has directed programs in neuropharmacology, drug discovery, and clinical therapeutics and organized Consortia focused on ways to accelerate the development and clinical application of radiotracers in clinical research. She has provided leadership for many programs, including: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders, the National Cooperative Drug/Device Discovery/Development Groups for the Treatment of Mental Disorders, and First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders. Dr. Brady serves as co-chair of the Neuroscience Steering Committee for the Biomarkers Consortium, a public-private research partnership of the Foundation for the National Institutes of Health (FNIH) that focuses on discovery, development, and qualification of biological markers to support drug development, preventive medicine, and medical diagnostics. From 2004-2013, she co-led the Molecular Libraries and Imaging Program, a trans-NIH Common Fund initiative to provide biomedical researchers access to small organic molecules that can be used as chemical probes to study the functions of genes, cells, and biochemical pathways in health and disease. Dr. Brady was trained in pharmacology and neuroscience. She completed her Ph.D. at Emory University School of Medicine, followed by post-doctoral work and research positions at the Uniformed Services University of the Health Sciences and the NIMH Intramural Research Program. She is the author of more than 70 peer reviewed scientific publications and is a member of the Society for Neuroscience and a Fellow in the American College of Neuropsychopharmacology. Dr. Brady has received NIH Director’s Awards and NIH Merit Awards in recognition of her activities in biomarker development and drug development for mental disorders.